EE427 Annual Cost Savings From the Use of Empagliflozin Over DPP4I in Select Asia-Pacific Countries – Estimates Based on the Emprise East Asia Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.673
https://www.valueinhealthjournal.com/article/S1098-3015(22)02877-7/fulltext
Title :
EE427 Annual Cost Savings From the Use of Empagliflozin Over DPP4I in Select Asia-Pacific Countries – Estimates Based on the Emprise East Asia Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02877-7&doi=10.1016/j.jval.2022.09.673
First page :
Section Title :
Open access? :
No
Section Order :
10207